The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Open accessAbstract
BACKGROUND: Faecal microbiota transplantation [FMT] has been investigated as a potential treatment for inflammatory bowel disease [IBD]. We thus performed a systematic review and meta-analysis assessing the effectiveness and safety of FMT in IBD. METHODS: A systematic review was conducted until January 2017. Studies were excluded if patients had co-infection or data were pooled across disease subtypes (ulcerative colitis [UC], Crohn's disease [CD], pouchitis). Clinical remission was established as the primary outcome. Pooled effect sizes and 95% confidence intervals were obtained using the random effects model. RESULTS: In all, 53 studies were included [41 in UC, 11 in CD, 4 in pouchitis]. Overall, 36% [201/555] of UC, 50.5% [42/83] of CD, and 21.5% [5/23] of pouchitis patients achieved clinical remission. Among cohort studies, the pooled proportion achieving clinical remission was 33% (95% confidence interval [CI] = 23%-43%] for UC and 52% [95% CI = 31%-72%] for CD, both with moderate risk of heterogeneity. For four RCTs in UC, significant benefit in clinical remission (pooled odds ratios [[P-OR] = 2.89, 95% CI = 1.36-6.13, p = 0.006) with moderate heterogeneity [Cochran's Q, p = 0.188; I2 = 37%] was noted. Sub-analyses suggest remission in UC improved with increased number of FMT infusions and lower gastrointestinal tract administration. Most adverse events were transient gastrointestinal complaints. Microbiota analysis was performed in 24 studies, with many identifying increased diversity and a shift in recipient microbiota profile towards the donor post-FMT. CONCLUSIONS: FMT appears effective in UC remission induction, but long-term durability and safety remain unclear. Additional well-designed controlled studies of FMT in IBD are needed, especially in CD and pouchitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The results showed that the rates of clinical remission in UC, CD, and pouchitis were 36, 50.5, and 21.5%, respectively.”
From Stress triggers flare of inflammatory bowel disease in children and adults (2019) · cites this paper as [146]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Feagan, B. G., Rutgeerts, P. J., Sands, B. E., Hanauer, S. B., Colombel, J., Sandborn, W. J., Assche, G. V., Axler, J. L., Kim, H. J., Danese, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215734 · Cited by 2,892
2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group
Furlan, A. D., Pennick, V., Bombardier, C., & van Tulder, M. (2009) · Spine · doi:10.1097/brs.0b013e3181b1c99f · Cited by 1,663
Moayyedi, P., Surette, M. G., Kim, P. T., Libertucci, J., Wolfe, M., Onischi, C., Armstrong, D., Marshall, J. K., Kassam, Z., Reinisch, W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.001 · Cited by 1,499
Paramsothy, S., Kamm, M. A., Kaakoush, N. O., Walsh, A. J., van den Bogaerde, J., Samuel, D., Leong, R. W. L., Connor, S., Ng, W., Paramsothy, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30182-4 · Cited by 1,276
Research works printed but not linked: 6
- Borody T Leis S McGrath K . Treatment of chronic constipation and colitis using human probiotic infusions. In: Probiotics, Prebiotics and New Foods Conference; September 2–4, 2001; Rome: Universita Urbaniana.
- 2013, Safety of fecal microbiota transplantation [FMT] in immunocompromised [IC] patients with inflammatory bowel disease [IBD], Am J Gastroenterol, 108, S556
- 2015;, Impact of antibiotic treatment before faecal microbiota transplantation [FMT] in chronic active ulcerative colitis, United European Gastroenterol J, 3, A437
- 2016, Safety and efficacy of fecal microbiota transplant in children with inflammatory bowel disease, J Pediatr Gastroenterol Nutr, 63, S212
- 2016, A randomized, placebo-controlled trial of fecal microbial transplantation for pediatric ulcerative colitis [Pedifetch Trial], J Pediatr Gastroenterol Nutr, 63, S79
- Fecal microbiota transplantation via colonoscopy is safe and effective in active ulcerative colitis. In: Advances in Inflammatory Bowel Diseases
Cited by
Sorted by citations
Items 101–200 of 436
Quraishi, M. N., Shaheen, W., Oo, Y. H., & Iqbal, T. H. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13397 · Cited by 65
ECCO Topical Review: Refractory Inflammatory Bowel Disease
Raine, T., Verstockt, B., Kopylov, U., Κarmiris, K., Goldberg, R., Atreya, R. N., Burisch, J. M., Burke, J. P., Ellul, P., Hedin, C. R. H., et al. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab112 · Cited by 58
Postbiotic-Enabled Targeting of the Host-Microbiota-Pathogen Interface: Hints of Antibiotic Decline?
Puccetti, M., Xiroudaki, S., Ricci, M., & Giovagnoli, S. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070624 · Cited by 59
Fecal microbiota transplantation for Crohn’s disease: a systematic review and meta-analysis
Cheng, F., Huang, Z., Wei, W., & Li, Z. (2021) · Techniques in Coloproctology · doi:10.1007/s10151-020-02395-3 · Cited by 64
Microbial determinants of effective donors in faecal microbiota transplantation for UC
Haifer, C., Luu, L. D. W., Paramsothy, S., Borody, T. J., Leong, R. W. L., & Kaakoush, N. O. (2022) · Gut · doi:10.1136/gutjnl-2022-327742 · Cited by 58
Zhang, Z., Mocanu, V., Deehan, E. C., Hotte, N., Zhu, Y., Wei, S., Kao, D. H., Karmali, S., Birch, D. W., Walter, J., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2345134 · Cited by 59
Goldenberg, S. D., Batra, R., Beales, I., Digby-Bell, J. L., Irving, P. M., Kellingray, L., Narbad, A., & Elumogo, N. (2018) · Infectious Diseases and Therapy · doi:10.1007/s40121-018-0189-y · Cited by 56
Recent advances and emerging therapies in the non-surgical management of ulcerative colitis
Wehkamp, J., & Stange, E. F. (2018) · F1000Research · doi:10.12688/f1000research.15159.1 · Cited by 54
Allegretti, J. R., Kelly, C. R., Grinspan, A. M., Mullish, B. H., Hurtado, J., Carrellas, M., Marcus, J., Marchesi, J. R., McDonald, J. A. K., Gerardin, Y., et al. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa283 · Cited by 54
The gut virome in inflammatory bowel diseases
Liang, G., Güemes, A. G. C., Albenberg, L. G., & Bushman, F. D. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.10.005 · Cited by 53
Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
Nishida, A., Nishino, K., Sakai, K., Owaki, Y., Noda, Y., & Imaeda, H. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i23.3317 · Cited by 52
The potential therapeutic role of Lactobacillus reuteri for treatment of inflammatory bowel disease.
Wang, H., Zhou, C., Huang, J., Kuai, X., & Shao, X. (2020) · PubMed Central · Cited by 51
Translating the gut microbiome: ready for the clinic?
Lynch, S. V., Ng, S. C., Shanahan, F., & Tilg, H. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0204-0 · Cited by 52
Stripling, J. T., & Rodríguez, M. (2018) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2018.08.010 · Cited by 50
Chu, N. D., Crothers, J. W., Nguyen, L. T. T., Kearney, S. M., Smith, M. B., Kassam, Z., Collins, C. C., Xavier, R. J., Moses, P. L., & Alm, E. J. (2021) · mBio · doi:10.1128/mbio.00975-21 · Cited by 53
An update on fecal microbiota transplantation for the treatment of gastrointestinal diseases
Waller, K. M. J., Leong, R. W. L., & Paramsothy, S. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15731 · Cited by 49
Zhao, H. L., Chen, S. Z., Xu, H. M., Zhou, Y. L., He, J., Huang, H. L., Xu, J., & Nie, Y. Q. (2020) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12933 · Cited by 48
Gut dysbiosis and paediatric Crohn's disease
Brusaferro, A., Cavalli, E., Farinelli, E., Cozzali, R., Principi, N., & Esposito, S. (2018) · Journal of Infection · doi:10.1016/j.jinf.2018.10.005 · Cited by 48
The Role of Fecal Microbiota Transplantation in IBD
Fanizzi, F., D’Amico, F., Bombassaro, I., Zilli, A., Furfaro, F., Parigi, T. L., Cicerone, C., Fiorino, G., Peyrin‐Biroulet, L., Danese, S., et al. (2024) · Microorganisms · doi:10.3390/microorganisms12091755 · Cited by 49
Kedia, S., Ghosh, T. S., Jain, S., Desigamani, A., Kumar, A., Gupta, V., Bopanna, S., Yadav, D. P., Goyal, S., Makharia, G. K., et al. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15232 · Cited by 49
Smith, B. J., Piceno, Y. M., Zydek, M., Zhang, B., Syriani, L. A., Terdiman, J. P., Kassam, Z., Ma, A. I., Lynch, S. V., Pollard, K. S., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09307-5 · Cited by 46
Zhou, S., Cui, Y., Zhang, Y., Zhao, T., & Cong, J. (2023) · International Journal of Colorectal Disease · doi:10.1007/s00384-023-04354-4 · Cited by 53
Fecal microbiota transplantation ameliorates active ulcerative colitis
Chen, H., Huang, H., Xu, H., Luo, Q., He, J., Li, Y., Zhou, Y., Nie, Y., & Zhou, Y. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8512 · Cited by 46
Emerging Therapies in Inflammatory Bowel Disease: A Comprehensive Review
Appiah, J. K., Hayat, U., Garg, N., Asante, R., Donneyong, E., Haider, M. U., Patel, P., Khan, Z. H., & Siddiqui, A. A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14176119 · Cited by 50
Management of the Elderly Inflammatory Bowel Disease Patient
Hruz, P. L., Juillerat, P., Kullak-Ublick, G. A., Schoepfer, A. M., Mantzaris, G. J., Rogler, G., & on behalf of Swiss IBDnet, A. O. W. G. O. T. S. S. O. G. (2020) · Digestion · doi:10.1159/000503099 · Cited by 44
Marrs, T., & Walter, J. (2021) · Allergy · doi:10.1111/all.14750 · Cited by 44
Probiotics as a therapeutic strategy in obesity and overweight: a systematic review
Tomé-Castro, X. M., Rodríguez-Arrastia, M. J., Cardona, D., Rueda‐Ruzafa, L., Molina‐Torres, G., & Román, P. (2021) · Beneficial Microbes · doi:10.3920/bm2020.0111 · Cited by 43
Takahashi, M., Ishikawa, D., Sasaki, T., Lu, Y., Kuwahara‐Arai, K., Kamei, M., Shibuya, T., Osada, T., Hiramatsu, K., & Nagahara, A. (2018) · Journal of Applied Microbiology · doi:10.1111/jam.14167 · Cited by 44
A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression
Iruzubieta, P., Medina, J. M., Fernández-López, R., Crespo, J., & de la Cruz, F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051369 · Cited by 44
The Evolving Landscape of Fecal Microbial Transplantation
Shao, T., Hsu, R., Hacein-Bey, C., Zhang, W., Gao, L., Kurth, M. J., Zhao, H., Shuai, Z., & Leung, P. S. C. (2023) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-023-08958-0 · Cited by 43
Huang, Z., Li, Y., Park, H., Ho, M., Bhardwaj, K., Sugimura, N., Lee, H. W., Meng, H., Ebert, M. P., Chao, K., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2237645 · Cited by 41
Garavaglia, B., Vallino, L., Amoruso, A., Pane, M., Ferraresi, A., & Isidoro, C. (2024) · Aspects of Molecular Medicine · doi:10.1016/j.amolm.2024.100056 · Cited by 48
Understanding the Scope of Do-It-Yourself Fecal Microbiota Transplant
Ekekezie, C., Perler, B. K., Wexler, A., Duff, C., Lillis, C. J., & Kelly, C. R. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000499 · Cited by 41
Personalized Clinical Phenotyping through Systems Medicine and Artificial Intelligence
Cesario, A., D’Oria, M., Bove, F., Privitera, G., Boškoski, I., Pedicino, D., Boldrini, L., Erra, C., Loreti, C., Liuzzo, G., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11040265 · Cited by 41
A New Biomarker of Fecal Bacteria for Non-Invasive Diagnosis of Colorectal Cancer
Yao, Y., Ni, H., Wang, X., Xu, Q., Zhang, J., Jiang, L., Wang, B., Song, S., & Zhu, X. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.744049 · Cited by 43
Non-alcoholic fatty liver disease and obesity: the role of the gut bacteria
Schwenger, K. J. P., Bolzon, C. M., Li, C., & Allard, J. P. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1844-5 · Cited by 40
Current and future applications of fecal microbiota transplantation for children
Chen, C.-C., & Chiu, C. (2021) · Biomedical Journal · doi:10.1016/j.bj.2021.11.004 · Cited by 41
Khan, R., Roy, N., Ali, H., & Naeem, M. (2022) · Gastroenterology Research and Practice · doi:10.1155/2022/9999925 · Cited by 41
Zhang, B., Yang, L., Ning, H., Cao, M., Chen, Z., Chen, Q., Lian, G., Tang, H., Wang, Q., Wang, J., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02159-21 · Cited by 41
Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea
Gweon, T., Lee, Y. J., Kim, K. O., Yim, S. K., Soh, J. S., Kim, S. Y., Park, J. J., Shin, S. Y., Lee, T. H., Choi, C. H., et al. (2022) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm21221 · Cited by 38
Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation
Ткач, С. М., Dorofeyev, A., Kuzenko, I., Boyko, N., Falalyeyeva, T. M., Boccuto, L., Scarpellini, E., Kobyliak, N. M., & Abenavoli, L. (2022) · Medicina · doi:10.3390/medicina58010084 · Cited by 39
The gut microbiome dysbiosis and regulation by fecal microbiota transplantation: umbrella review
Zhang, X., Luo, X., Liang, T. G., Yue, P., Li, M., Liu, K., Zhu, D., Huang, C., Shi, Q., Yang, L., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1286429 · Cited by 38
Yue, B., Yu, Z., Lv, C., Geng, X., Wang, Z., & Dou, W. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i30.4378 · Cited by 38
Oral Microbiota Transplant in Dogs with Naturally Occurring Periodontitis
Beikler, T., Kaymaz, K., Chan, Y., Weiher, B., Selbach, S., Peters, U., Klocke, A., Watt, R. M., & Flemmig, T. F. (2021) · Journal of Dental Research · doi:10.1177/0022034521995423 · Cited by 37
The Modification of the Gut Microbiota via Selected Specific Diets in Patients with Crohn’s Disease
Knez, E., Wzorek, K., Folwarski, M., Kaźmierczak-Siedlecka, K., Stachowska, L., Przewłócka, K., Stachowska, E., & Skonieczna‐Żydecka, K. (2021) · Nutrients · doi:10.3390/nu13072125 · Cited by 41
Qu, Z., Tian, P., Yang, B. K., Zhao, J., Wang, G., & Chen, W. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120719 · Cited by 37
Faecal microbiota transplantation: a regulatory hurdle?
Verbeke, F., Janssens, Y., Wynendaele, E., & Spiegeleer, B. D. (2017) · BMC Gastroenterology · doi:10.1186/s12876-017-0687-5 · Cited by 36
Current, experimental, and future treatments in inflammatory bowel disease: a clinical review
Hvas, C. L., Bendix, M., Dige, A. K., Dahlerup, J. F., & Agnholt, J. S. (2018) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2018.1469144 · Cited by 37
Lacroix, V., Cassard, A., Mas, E., & Barreau, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011255 · Cited by 36
Gut bacteriome in inflammatory bowel disease: An update on recent advances
Bajaj, A., Markandey, M., Kedia, S., & Ahuja, V. (2024) · Indian Journal of Gastroenterology · doi:10.1007/s12664-024-01541-1 · Cited by 42
Exploring the Gut Microbiome’s Role in Inflammatory Bowel Disease: Insights and Interventions
Gyriki, D., Nikolaidis, C. G., Stavropoulou, E., Bezirtzoglou, I., Tsigalou, C., Vradelis, S., & Bezirtzoglou, E. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14050507 · Cited by 40
NOD2 and bacterial recognition as therapeutic targets for Crohn’s disease
de Bruyn, M., & Vermeire, S. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1397627 · Cited by 38
Jeon, S. R., Chai, J., Kim, C., & Lee, C. (2018) · Current Infectious Disease Reports · doi:10.1007/s11908-018-0627-8 · Cited by 32
Delaune, V., Orci, L. A., Lacotte, S., Peloso, A., Schrenzel, J., Lazarević, V., & Toso, C. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1518424 · Cited by 46
Woodhouse, C., Patel, V., Goldenberg, S. D., Fueyo, A. S., China, L., O'Brien, A. J., Flach, C., Douiri, A., & Shawcross, D. L. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-023518 · Cited by 37
Advances in the understanding of the intestinal micro-environment and inflammatory bowel disease
Yan, P., & Li, J. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000718 · Cited by 35
Zhou, B.-G., Liu, F., Zhao, H., Zhang, X., Wang, H.-Y., & Liu, D. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113211 · Cited by 35
Liu, Y., Li, X., Chen, Y., Yao, Q., Zhou, J., Wang, X., Meng, Q., Ji, J., Yu, Z., & Chen, X. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1556827 · Cited by 37
Bretto, E., Caviglia, G. P., Saracco, G. M., Bugianesi, E., & Ribaldone, D. G. (2025) · Biomedicines · doi:10.3390/biomedicines13081807 · Cited by 41
Glycans as critical regulators of gut immunity in homeostasis and disease
Dias, A. M., Pereira, M. S., Padrão, N., Alves, I., Marcos‐Pinto, R., Lago, P., & Pinho, S. S. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.07.007 · Cited by 35
The role of faecal microbiota transplantation in the treatment of inflammatory bowel disease
Haifer, C., Leong, R. W. L., & Paramsothy, S. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.08.009 · Cited by 32
The impact of tobacco smoking on treatment choice and efficacy in inflammatory bowel disease
Nicolaides, S., Vasudevan, A., Long, T., & van Langenberg, D. R. (2020) · Intestinal Research · doi:10.5217/ir.2020.00008 · Cited by 34
Translating Microbiome Research From and To the Clinic
Zhang, Z. J., Lehmann, C. J., Cole, C. G., & Pamer, E. G. (2022) · Annual Review of Microbiology · doi:10.1146/annurev-micro-041020-022206 · Cited by 33
Washed microbiota transplantation improves patients with metabolic syndrome in South China
Wu, L., Lu, X., Lin, D.-J., Chen, W.-J., Xue, X.-Y., Liu, T., Xu, J., Xie, Y.-T., Li, M.-Q., Lin, W.-Y., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1044957 · Cited by 34
Immune Checkpoint Inhibitor Enterocolitis vs Idiopathic Inflammatory Bowel Disease
Thomas, A. S., Hanauer, S. B., & Wang, Y. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.10.004 · Cited by 32
Intestinal Microbiota in Common Chronic Inflammatory Disorders Affecting Children
Torun, A., Hupalowska, A., Trzonkowski, P., Kierkuś, J., & Pyrzyńska, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.642166 · Cited by 40
Host–pathobiont interactions in Crohn’s disease
Caruso, R., Lo, B. C., Chen, G., & Núñez, G. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00997-y · Cited by 35
Tyakht, A., Manolov, A. I., Kanygina, A. V., Ischenko, D. S., Kovarsky, B. A., Popenko, A., Pavlenko, A. V., Elizarova, A., Rakitina, D. V., Baikova, I. P., et al. (2018) · BMC Genomics · doi:10.1186/s12864-018-5306-5 · Cited by 33
Jacob, E. M., Borah, A., Pillai, S. C., & Kumar, D. S. (2020) · Nanomaterials · doi:10.3390/nano10122460 · Cited by 32
UEG Week 2018 Poster Presentations
Pittet, V., Aslan, N., Fournier, N., Decollogny, A., Schoepfer, A., Seibold, F., & Rodondi, P. Y. (2018) · United European Gastroenterology Journal · doi:10.1177/2050640618792819 · Cited by 32
Fecal Microbiota Transplantation: Beyond Clostridium difficile
Millan, B., Laffin, M., & Madsen, K. L. (2017) · Current Infectious Disease Reports · doi:10.1007/s11908-017-0586-5 · Cited by 31
Yan, H., Vestergaard, G., Deng, L., Kot, W., Thymann, T., Brunse, A., & Nielsen, D. S. (2022) · npj Biofilms and Microbiomes · doi:10.1038/s41522-022-00310-2 · Cited by 31
Ricciuto, A., Sherman, P. M., & Laxer, R. M. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108415 · Cited by 33
Olesen, S. W., & Gerardin, Y. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa170 · Cited by 29
Fecal Microbiota Transplantation in Gastrointestinal and Extraintestinal Disorders
Ianiro, G., Segal, J. P., Mullish, B. H., Quraishi, M. N., Porcari, S., Fabiani, G., Gasbarrini, A., & Cammarota, G. (2020) · Future Microbiology · doi:10.2217/fmb-2020-0061 · Cited by 31
Collier, A. J., Gómez, D. E., Monteith, G. J., Plattner, B. L., Verbrugghe, A., Webb, J. A., Weese, J. S., & Blois, S. L. (2022) · PLoS ONE · doi:10.1371/journal.pone.0276295 · Cited by 30
Li, H., Li, H., Stanton, C., Ross, R. P., Zhao, J., Chen, W., & Yang, B. K. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.129346 · Cited by 31
New targets for the treatment of ulcerative colitis: Gut microbiota and its metabolites
Li, H., Pan, M., Li, Y., Cui, M., & Zhang, M. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.05.006 · Cited by 29
Fecal transplants as a microbiome-based therapeutic
Kaakoush, N. O. (2020) · Current Opinion in Microbiology · doi:10.1016/j.mib.2020.05.008 · Cited by 31
Masu, Y., Kanazawa, Y., Kakuta, Y., Shimoyama, Y., Onodera, M., Naito, T., Moroi, R., Kuroha, M., Kimura, T., Shiga, H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-96289-5 · Cited by 29
Uncovering the cause of ulcerative colitis
Roberts‐Thomson, I. C., Bryant, R. V., & Costello, S. P. (2019) · JGH Open · doi:10.1002/jgh3.12216 · Cited by 29
Park, S., Kang, Y., Koh, H., & Kim, S. (2020) · Korean Journal of Pediatrics · doi:10.3345/cep.2019.00500 · Cited by 28
Merali, N., Chouari, T. A. M., Kayani, K., Rayner, C. J., Jiménez, J. I., Krell, J., Giovannetti, E., Bagwan, I., Relph, K., Rockall, T., et al. (2022) · Cancers · doi:10.3390/cancers14041020 · Cited by 29
Zhang, S., Deng, F., Chen, J., Chen, F., Wu, Z., Li, L., & Hou, K. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1075201 · Cited by 30
The Role of Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease
Stojek, M., Jabłońska, A., & Adrych, K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184055 · Cited by 28
Fecal Microbial Transplantation in Critically Ill Patients—Structured Review and Perspectives
Cibulková, I., Řehořová, V., Hajer, J., & Duška, F. (2021) · Biomolecules · doi:10.3390/biom11101459 · Cited by 27
Traditional Chinese Medicine Alleviates Ulcerative Colitis via Modulating Gut Microbiota
Feng, W., Zhu, L., & Shen, H. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/8075344 · Cited by 27
Abenavoli, L., Scarpellini, E., Paravati, M. R., Scarlata, G. G. M., Boccuto, L., Tilocca, B., Roncada, P., & Luzza, F. (2023) · Nutrients · doi:10.3390/nu15163569 · Cited by 30
Clinical Review on the Utility of Fecal Microbiota Transplantation in Immunocompromised Patients
Abu‐Sbeih, H., Ali, F. S., & Wang, Y. (2019) · Current Gastroenterology Reports · doi:10.1007/s11894-019-0677-6 · Cited by 27
Basson, A. R., Gomez-Nguyen, A., Menghini, P., Buttó, L. F., Martino, L. D., Aladyshkina, N. A., Ösme, A., LaSalla, A., Fischer, D., Ezeji, J. C., et al. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz242 · Cited by 26
van Lingen, E., Nooij, S., Terveer, E. M., Crossette, E. M., Prince, A., Bhattarai, S. K., Watson, A., Galazzo, G., Menon, R., Szabady, R. L., et al. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae043 · Cited by 28
Chen, H., Li, H., & Liu, Z. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820935188 · Cited by 29
Inflammatory bowel disease: pathogenesis, diagnosis and current therapeutic approach
Silaghi, A. M., Constantin, V. D., Socea, B., Banu, P., Sandu, V., Andronache, L., Dumitriu, A. S., & Păunica, S. (2022) · Journal of Mind and Medical Sciences · doi:10.22543/7674.91.p5677 · Cited by 26
Borgers, J. S. W., Burgers, F. H., Terveer, E. M., van Leerdam, M. E., Korse, C. M., Kessels, R., Flohil, C. C., Blank, C. U., Schumacher, T. N., van Dijk, M., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-10457-y · Cited by 29
Haifer, C., Saikal, A., Paramsothy, R., Kaakoush, N. O., Leong, R. W., Borody, T. J., Kamm, M. A., & Paramsothy, S. (2021) · Gut · doi:10.1136/gutjnl-2020-323581 · Cited by 25
Yang, L., Li, X.-M., Duan, H.-Y., Yang, K., & Ye, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1398652 · Cited by 27
Hsu, M., Tun, K. M., Batra, K., Haque, L., Vongsavath, T., & Hong, A. S. (2023) · Microorganisms · doi:10.3390/microorganisms11051272 · Cited by 26
Xiao, Y., Wang, Y., Tong, B., Gu, Y., Zhou, X., Ning, Z. H., Xu, X., Yin, X., Kou, Y., Tan, Y. Q., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.01154-23 · Cited by 27
Luu, L. D. W., Pandey, A., Paramsothy, S., Ngo, C., Castaño‐Rodríguez, N., Liu, C., Kamm, M. A., Borody, T. J., Man, S. M., & Kaakoush, N. O. (2024) · Nature Communications · doi:10.1038/s41467-024-46983-5 · Cited by 25
Lee, J., Kim, K. S., Koh, H., Lee, D.-W., & Kang, N. J. (2022) · Current Developments in Nutrition · doi:10.1093/cdn/nzac110 · Cited by 26
Metadata
- Authors
- Paramsothy, S., Paramsothy, R., Rubin, D. T., Kamm, M. A., Kaakoush, N. O., Mitchell, H. M., & Castaño-Rodríguez, N.
- Affiliations
- UNSW Sydney (AU)
- Liverpool Hospital (AU)
- University of Chicago (US)
- The University of Melbourne (AU)
- Venue
- Journal of Crohn s and Colitis
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-05-09
- Volume
- 11
- Issue
- 10
- Pages
- 1180-1199
- ISSN
- 1873-9946 (ISSN-L)
- 1876-4479
- OpenAlex
- W2586374101
- Cited by
- 436
- References
- 71
- Citations by year
- 2026: 21 · 2025: 36 · 2024: 41 · 2023: 39 · 2022: 56 · 2021: 56 · 2020: 77 · 2019: 62 · 2018: 40 · 2017: 7
- FWCI
- 6.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Crohn s and Colitis (publishedVersion)
- PubMed (publishedVersion)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- UNSWorks (UNSW Sydney) (submittedVersion, cc-by-nc-nd)
- Funders
- Cancer Institute NSW
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Keywords
- fecal microbiota transplantation, inflammatory bowel disease
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Colitis, Ulcerative, Crohn Disease, Humans, Inflammatory Bowel Diseases, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
